Lifestyle interventions are cost-effective in people with different levels of diabetes risk - Results from a modeling study

被引:93
作者
Jacobs-van der Bruggen, Monique A. M. [1 ]
Bos, Griet [1 ]
Bemelmans, Wanda J. [1 ]
Hoogenveen, Rudolf T. [1 ]
Vijgen, Sylvia M. [1 ]
Baan, Caroline A. [1 ]
机构
[1] Natl Inst Publ Hlth & Environm, Dept Prevent & Hlth Serv Res, NL-3720 BA Bilthoven, Netherlands
关键词
D O I
10.2337/dc06-0690
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - In the current study we explore the long-term health benefits and costeffectiveness of both a community-based lifestyle program for the general population (community intervention) and an intensive lifestyle intervention for obese adults, implemented in a health care setting (health care intervention). RESEARCH DESIGN AND METHODS - Short-term intervention effects on BMI and physical activity were estimated from the international literature. The National Institute for Public Health and the Environment Chronic Diseases Model was used to project lifetime health effects and effects on health care costs for minimum and maximum estimates of short-term intervention effects- Cost-effectiveness was evaluated from a health care perspective and included intervention costs and related and unrelated medical costs. Effects and costs were discounted at 1.5 and 4.0% annually. RESULTS - One new case of diabetes per 20 years was prevented for every 7-30 participants in the health care intervention and for every 300-1,500 adults in the community intervention. Intervention costs needed to prevent one new case of diabetes (per 20 years) were lower for the community intervention (2,000-9,000 euro) than for the health care intervention (5,000-21,000 euro). The cost-effectiveness ratios were 3,100-3,900 euro per quality-adjusted life-year (QALY) for the community intervention and 3,900-5,500 euro per QALY for the health care intervention. CONCLUSIONS - Health care interventions for high-risk groups and community-based lifestyle interventions targeted to the general population (low risk) are both cost-effective ways of curbing the growing burden of diabetes.
引用
收藏
页码:128 / 134
页数:7
相关论文
共 60 条
  • [11] Diabet Prevention Program Res Grp, 2003, DIABETES CARE, V26, P2518, DOI 10.2337/diacare.26.9.2518
  • [12] PREVENTION OF TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS BY DIET AND PHYSICAL EXERCISE - THE 6-YEAR MALMO FEASIBILITY STUDY
    ERIKSSON, KF
    LINDGARDE, F
    [J]. DIABETOLOGIA, 1991, 34 (12) : 891 - 898
  • [13] Cost-effectiveness of face-to-face smoking cessation interventions:: A dynamic modeling study
    Feenstra, TL
    Hamberg-van Reenen, HH
    Hoogenveen, RT
    Rutten-van Mölken, MPMH
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 178 - 190
  • [14] The impact of aging and smoking of the future burden of chronic obstructive pulmonary disease -: A model analysis in the Netherlands
    Feenstra, TL
    van Genugten, MLL
    Hoogenveen, RT
    Wouters, EF
    Rutten-van Mölken, MPMH
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (04) : 590 - 596
  • [15] Weight cycling and the risk of developing type 2 diabetes among adult women in the United States
    Field, AE
    Manson, JE
    Laird, N
    Williamson, DF
    Willett, WC
    Colditz, GA
    [J]. OBESITY RESEARCH, 2004, 12 (02): : 267 - 274
  • [16] EVALUATION OF THE HEART TO HEART PROJECT - LESSONS FROM A COMMUNITY-BASED CHRONIC DISEASE PREVENTION PROJECT
    GOODMAN, RM
    WHEELER, FC
    LEE, PR
    [J]. AMERICAN JOURNAL OF HEALTH PROMOTION, 1995, 9 (06) : 443 - 455
  • [17] Combining risk estimates from observational studies with different exposure cutpoints: A meta-analysis on body mass index and diabetes type 2
    Hartemink, Nienke
    Boshuizen, Hendriek C.
    Nagelkerke, Nico J. D.
    Jacobs, Monique A. M.
    van Houwelingen, Hans C.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (11) : 1042 - 1052
  • [18] The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance
    Herman, WH
    Hoerger, TJ
    Brandle, M
    Hicks, K
    Sorensen, S
    Zhang, P
    Hamman, RF
    Ackermann, RT
    Engelgau, MM
    Ratner, RE
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (05) : 323 - 332
  • [19] Herman WH, 2003, DIABETES CARE, V26, P36
  • [20] A dynamic population model of disease progression in COPD
    Hoogendoorn, M
    Rutten-van Mölken, MPMH
    Hoogenveen, RT
    van Genugten, MLL
    Buist, AS
    Wouters, EFM
    Feenstra, TL
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (02) : 223 - 233